Alteration in mitochondrial dynamics has been implicated in many neurodegenerative diseases. Mitochondrial apoptosis inducing factor (AIF) plays a key role in multiple cellular and disease processes. Using immunoblotting and flow cytometry analysis with Harlequin mutant mice that have a proviral insertion in the AIF gene, we first revealed that mitofusion 1 (Mfn1), a key mitochondrial fusion protein, is significantly diminished in Purkinje cells of the Harlequin cerebellum. Next, we investigated the cerebellar pathology of Harlequin mice in an age-dependent fashion, and identified a striking process of progressive and patterned Purkinje cell degeneration. Using immunohistochemistry with zebrin II, the most studied compartmentalization marker in the cerebellum, we found that zebrin II-negative Purkinje cells first started to degenerate at 7 months of age. By 11 months of age, almost half of the Purkinje cells were degenerated. Subsequently, most of the Purkinje cells disappeared in the Harlequin cerebellum. The surviving Purkinje cells were concentrated in cerebellar lobules IX and X, where these cells were positive for heat shock protein 25 and resistant to degeneration. We further showed that the patterned Purkinje cell degeneration was dependent on caspase but not poly(ADP-ribose) polymerase-1 (PARP-1) activation, and confirmed the marked decrease of Mfn1 in the Harlequin cerebellum. Our results identified a previously unrecognized role of AIF in Purkinje cell degeneration, and revealed that AIF deficiency leads to altered mitochondrial fusion and caspase-dependent cerebellar Purkinje cell loss in Harlequin mice. This study is the first to link AIF and mitochondrial fusion, both of which might play important roles in neurodegeneration.
Introduction
Mitochondria are the power-house in most eukaryotic cells. They exist as a dynamic network that constantly remodels itself through the opposing processes of mitochondrial fusion and fission, which critically control mitochondrial morphology and function (Detmer and Chan, 2007) . In addition, they play important roles in regulating cell homeostasis and cell death (McBride et al., 2006) . Mitochondrial dysfunction is a critical factor in many neurodegenerative disorders, such as Huntington's disease, Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and Friedreich's ataxia (Kwong et al., 2006; Reddy, 2008) , and has been implicated as an early event in most late-onset neurodegenerative diseases (Reddy, 2008) . Klein et al. (2002) reported a naturally occurring genetic mouse model of neurodegeneration, the Harlequin mouse, which carries an X-linked recessive mutation in the apoptosis inducing factor (AIF) gene due to a proviral insertion, resulting in an approximately 80% decrease in AIF expression. AIF is a 67 kDa flavoprotein, and is located in the mitochondrial intermembranous space in healthy cells (Susin et al., 1999a,b) . AIF shows homology with several bacterial nicotinamide adenine dinucleotide (NADH)-dependent ferrodoxin oxidoreductases (Susin et al., 1999b; Miramar et al., 2001) . Under apoptotic conditions, AIF is released from the mitochondria and translocates to the nucleus where it participates in apoptosis. In the nucleus, AIF binds to DNA and induces DNA fragmentation and nuclear condensation (Susin et al., 1999a,b; Cande et al., 2002) . Because AIF mediates poly(ADP-ribose) polymerase-1 (PARP-1)-dependent cell death that cannot be rescued by pan-caspase inhibitors, AIF is generally known to induce cell death via a caspase-independent mechanism (Liu et al., 1996; Yu et al., 2002) . The phenotype of Harlequin mice is characterized by progressive retinal neuron defects, including the degeneration of amacrine and ganglion cells, starting at 3 months of age. In addition, cerebellar granule neuron degeneration begins at 4 months of age with progressive ataxia symptoms, and the cerebellar neuron death in the Harlequin cerebellum appears to be mediated by oxidative stress (Klein et al., 2002) . However, loss of AIF leads to an increase in reactive oxygen species in various cell types in vitro Neurobiology of Disease 41 (2011) 445-457 
